Related Experiment Video
Updated: Jul 7, 2026
11:22
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
27.9K
The causality between gut microbiota and non-Hodgkin lymphoma: a two-sample bidirectional Mendelian randomization
1Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Frontiers in Microbiology
|June 11, 2024
Summary
This study used Mendelian randomization to investigate the causal link between gut microbiota (GM) and non-Hodgkin lymphoma (NHL). Researchers found 27 gut microbes causally associated with NHL, offering new insights for prevention and treatment.
Area of Science:
- Microbiome research
- Oncology
- Genetic epidemiology
Background:
- Emerging evidence suggests a link between gut microbiota (GM) and non-Hodgkin lymphoma (NHL).
- The precise causal relationship between GM and NHL remains to be definitively established.
- This study addresses the causality using a robust genetic approach.
Purpose of the Study:
- To investigate the causal relationship between specific gut microbes and the risk of developing non-Hodgkin lymphoma (NHL).
- To leverage Mendelian randomization (MR) to infer causality from observational data on GM and NHL.
- To identify potential microbial targets for NHL prevention and treatment strategies.
Main Methods:
- Utilized large-scale genetic data from the MiBioGen consortium for gut microbiota and the FinnGen R10 release for non-Hodgkin lymphoma (NHL).
- Employed the inverse variance weighted (IVW) method as the primary Mendelian randomization (MR) analysis.
- Conducted rigorous sensitivity analyses using Cochran's Q test, MR-Egger regression, MR-PRESSO, and Leave-one-out methods to ensure result validity.
Main Results:
- Identified a statistically significant causal association between 27 distinct gut microbial taxa and non-Hodgkin lymphoma (NHL).
- Found that 20 gut microbes showed a protective (negative) association with NHL risk, while 7 microbes indicated an increased risk (positive association).
- All identified causal associations were robust across multiple sensitivity analyses, with no evidence of reverse causality.
Conclusions:
- This Mendelian randomization study provides strong evidence for a causal role of specific gut microbes in non-Hodgkin lymphoma (NHL) development.
- The findings offer novel perspectives for the prevention, early detection, and therapeutic intervention of NHL by targeting the gut microbiome.
- Highlights the potential of microbiome modulation as a future strategy in onco-gastroenterology and lymphoma management.
Related Concept Videos
01:22Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...